Archives pour la catégorie ‘Risques biologiques’
-
Religious barriers to measles vaccination
-
Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013
-
A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States
04 mai 2016
-
Asymptomatic transmission and the resurgence of Bordetella pertussis
04 mai 2016
-
Analysis of the Auckland 2014 measles outbreak indicates that adolescents and young adults could benefit from catch-up vaccination
-
Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy
-
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015
04 mai 2016
-
Implementation of pertussis immunization in health-care personnel
-
Impact of universal gowning and gloving on health care worker clothing contamination
03 mai 2016
-
Many Hospital Isolation Gowns Fail Performance Tests
-
Vaccination against varicella as post-exposure prophylaxis in adults: a quantitative assessment
-
Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
09 septembre 2015
-
Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine
09 septembre 2015
-
Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study
-
Hepatitis B virus antibody levels 7 to 9 years after booster vaccination in Alaska native persons
09 septembre 2015
-
Evaluation of efficacy and effectiveness of live attenuated zoster vaccine
09 septembre 2015
